BLISOVI FE 1.5/30

Lupin Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 18, 2025
Approval ID: 5c5f2307-8679-4e34-9bcd-c22219b14a15
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Blisovi Fe 1.5/30(norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets*)1.5 mg/0.03 mg*Ferrous fumarate tablets are not USP for dissolution

Quick Stats

Total Products1

Labelers1

Label Sections37

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.